Mail

Canada markets close in 3 hours 44 minutes

S&P/TSX
21,799.00
+70.45(+0.32%)
S&P 500
5,035.19
+16.80(+0.33%)
DOW
38,036.26
+132.97(+0.35%)
CAD/USD
0.7302
+0.0021(+0.28%)
CRUDE OIL
78.63
-0.37(-0.47%)
Bitcoin CAD
80,929.24
+2,897.67(+3.71%)

MARKETS LIVE BLOG

STOCKS CLIMB AS RATE-HIKE FEARS FADE, WITH APPLE ON DECK

Bitcoin rebounds to US$59,000 following record ETFs outflow

Regen BioPharma, Inc. (RGBP)

Other OTC - Other OTC Delayed Price. Currency in USD

Add to watchlist

0.5700

-0.0051

(-0.89%)

As of 11:48AM EDT. Market open.

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	2.37M
Enterprise Value	2.98M
Trailing P/E	31.20
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	9.17
Price/Book (mrq)	N/A
Enterprise Value/Revenue	12.61
Enterprise Value/EBITDA	-3.62

Trading Information

Stock Price History

Beta (5Y Monthly)	2.79
52-Week Change ³	-62.90%
S&P500 52-Week Change ³	23.57%
52 Week High ³	2.5500
52 Week Low ³	0.4010
50-Day Moving Average ³	0.7405
200-Day Moving Average ³	1.2062

Share Statistics

Avg Vol (3 month) ³	14.68k
Avg Vol (10 day) ³	4.43k
Shares Outstanding ⁵	4.11M
Implied Shares Outstanding ⁶	3.75M
Float ⁸	4.11M
% Held by Insiders ¹	0.01%
% Held by Institutions ¹	0.00%
Shares Short ⁴	N/A
Short Ratio ⁴	N/A
Short % of Float ⁴	N/A
Short % of Shares Outstanding ⁴	N/A
Shares Short (prior month ) ⁴	N/A

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	1:1500
Last Split Date ³	Mar 06, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends	Sept 30, 2023
Most Recent Quarter (mrq)	Mar 31, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	-171.12%

Management Effectiveness

Return on Assets (ttm)	-84.06%
Return on Equity (ttm)	N/A

Income Statement

Revenue (ttm)	236.56k
Revenue Per Share (ttm)	0.06
Quarterly Revenue Growth (yoy)	0.00%
Gross Profit (ttm)	N/A
EBITDA	N/A
Net Income Avi to Common (ttm)	-839.79k
Diluted EPS (ttm)	-0.2400
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	78.11k
Total Cash Per Share (mrq)	0.02
Total Debt (mrq)	693.77k
Total Debt/Equity (mrq)	N/A
Current Ratio (mrq)	0.02
Book Value Per Share (mrq)	-1.26

Cash Flow Statement

Operating Cash Flow (ttm)	-482.07k
Levered Free Cash Flow (ttm)	-66.86k